Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin Oral Gel vs Mouthwash for Recurrent Aphthous Stomatitis
NCT06923605Phase 4Completed
- Sponsor
- Future University in Egypt
- Start
- Jul 2024
- Primary completion
- Dec 2024
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 4, randomised trial of Epoetin alfa RB in recurrent aphthous stomatitis (RAS) (3 arms), sponsored by Future University in Egypt. Primary endpoint: Pain Visual Analogue Scale (P-VAS) at 1 week. Started Jul 2024; status: completed.
02
Drugs
Epoetin alfa RB
03
Conditions
recurrent aphthous stomatitis (RAS)
Beyond the preview
Go deeper on NCT06923605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06923605.